树突细胞:癌症免疫力的核心合作伙伴
Léo Laoubi1,2, Elisa Gobbini1,3, Pierre Duplouye1
1Centre de Recherche en Cancérologie de Lyon, Centre Léon Bérard, INSERM U1052, CNRS UMR5286, Université Claude Bernard Lyon 1, Lyon, France.
Oncoimmunology
|November 14, 2025
概括
状细胞 (DCs) 是关键的免疫细胞,可以弥合先天性和适应性免疫. 本综述探讨了DC如何启动和调节抗瘤反应,与其他免疫细胞相互作用,并受到癌症免疫疗法的瘤微环境的影响.
科学领域:
- 免疫学 免疫学 免疫学
- 癌症生物学 癌症生物学
- 细胞免疫学 细胞免疫学
背景情况:
- 树突细胞 (DCs) 是关键的免疫细胞,弥合了先天性和适应性免疫.
- DCs捕获,处理,并向T细胞呈现瘤抗原,启动抗瘤反应.
研究的目的:
- 审查DCs在癌症免疫中的表型和功能多样性.
- 为了强调DC与瘤微环境中的其他免疫细胞的相互作用.
- 检查瘤信号和免疫抑制对DC功能和免疫治疗的影响.
主要方法:
- 在癌症免疫力中的树突细胞研究的文献综述.
- 分析瘤微环境中的DC相互作用.
- 检查影响DCs的瘤衍生信号和免疫抑制机制.
主要成果:
- DCs在癌症中表现出显著的表型和功能异质性.
- 与其他免疫细胞的DC相互作用对于有效的抗瘤免疫是至关重要的.
- 瘤微环境信号和免疫抑制会损害直流功能.
结论:
- 了解DC的多样性和功能对于开发有效的基于DC的癌症免疫疗法至关重要.
- 准DC介导的免疫反应对癌症治疗具有前途.
- 克服瘤诱导的免疫抑制对于成功的DC免疫疗法至关重要.
相关概念视频
T Cell Activation and Clonal Selection
14.6K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
14.6K
Antigen Presenting Cells
2.9K
The immune system is a complex network of cells and molecules that protects the body from foreign invaders. T cells, a type of white blood cell, play a crucial role in this process. They recognize and attack foreign substances, such as pathogens, that enter the body.
T cells require the help of antigen-presenting cells (APCs), which process foreign antigens into smaller fragments that can be recognized by T cells. These APCs are highly specialized cells that efficiently internalize antigens...
T cells require the help of antigen-presenting cells (APCs), which process foreign antigens into smaller fragments that can be recognized by T cells. These APCs are highly specialized cells that efficiently internalize antigens...
2.9K
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
Cell-mediated Immune Responses
83.4K
Overview
83.4K
Cytotoxic T Cells-mediated Immune Response
6.4K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
6.4K
Antigens Involved in Adaptive Immunity
1.3K
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
Complete Antigens
Complete antigens possess both immunogenicity and...
1.3K


